Minimally Invasive Approach for Myomectomy

ABSTRACT

Uterine fibroids are the most common benign tumor of the uterus in women of reproductive age. However, most of them are asymptomatic and do not require any treatment. Menorrhagia and pelvic pain are the most usual symptoms, and some women may present with infertility or pregnancy-related complications. In those with abnormal uterine bleeding, one should exclude other causes of abnormal vaginal bleeding including endometrial cancer. Diagnosis of uterine fibroid is established by pelvic ultrasonography with or without saline infusion hysterosonography. Management options depend on the patient's fertility potential and desire for future pregnancy. Submucous myoma should be treated by a hysteroscopic approach. Intramural and subserous myomas in women who opt for nonsurgical treatment could be treated with uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), or medical treatment such as selective gonadotropin-releasing hormone agonists, progesterone receptor modulators, or aromatase inhibitors. All interventions aside from hysterectomy provide temporary relief, although myomectomy, UAE, and HIFU provides more durable symptom relief relative to current medical management. Patients wishing to preserve their fertility are best treated by myomectomy, which can be done by laparoscopy. A laparoscopic approach is more advantageous than laparotomy, but laparoscopic suturing is more demanding. This can be overcome by robotic-assisted laparoscopic myomectomy.

KEYWORDS

Laparoscopy - laparoscopic myomectomy - hysteroscopy - hysteroscopic myomectomy - robotic-assisted myomectomy

REFERENCES

• 1 Day Baird D, Dunson D B, Hill M C, Cousins D, Schectman J M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.  Am J Obstet Gynecol. 2003;  188(1) 100-107
• 2 Haney A F. Clinical decision making regarding leiomyomata: what we need in the next millennium.  Environ Health Perspect. 2000;  108(suppl 5) 835-839
• 3 Nowak R A. Fibroids: pathophysiology and current medical treatment.  Baillieres Best Pract Res Clin Obstet Gynaecol. 1999;  13(2) 223-238
• 4 Marino J L, Eskenazi B, Warner M et al.. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study.  Hum Reprod. 2004;  19(10) 2350-2355
• 5 Buttram Jr V C. Uterine leiomyomata—aetiology, symptomatology and management.  Prog Clin Biol Res. 1986;  225 275-296
• 6 Seracchioli R, Rossi S, Govoni F et al.. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy.  Hum Reprod. 2000;  15(12) 2663-2668
• 7 Jourdain O, Descamps P, Abusada N et al.. Treatment of fibromas.  Eur J Obstet Gynecol Reprod Biol. 1996;  66(2) 99-107
• 8 de Kroon C D, de Bock G H, Dieben S W, Jansen F W. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis.  BJOG. 2003;  110(10) 938-947
• 9 Brooks P G. In the management of abnormal uterine bleeding, is office hysteroscopy preferable to sonography? The case for hysteroscopy.  J Minim Invasive Gynecol. 2007;  14(1) 12-14
• 10 Imai A, Sugiyama M, Furui T, Tamaya T. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.  J Obstet Gynaecol. 2003;  23(5) 518-520
• 11 Huang J Y, Kafy S, Dugas A, Valenti D, Tulandi T. Failure of uterine fibroid embolization.  Fertil Steril. 2006;  85(1) 30-35
• 12 Reinblatt S L, Krishnamurthy S, Valenti D, Tulandi T. Septic uterus after uterine artery embolization for uterine myomas triggered by endometrial biopsy.  J Obstet Gynaecol Can. 2008;  30(4) 344-346
• 13 Agdi M, Valenti D, Tulandi T. Intraabdominal adhesions after uterine artery embolization.  Am J Obstet Gynecol. 2008;  199(5) 482.e481-483
• 14 Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis G B. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome.  Am J Obstet Gynecol. 1996;  174(2) 654-658
• 15 Palomba S, Zupi E, Russo T et al.. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes.  Fertil Steril. 2007;  88(4) 942-951
• 16 Rossetti A, Sizzi O, Soranna L, Cucinelli F, Mancuso S, Lanzone A. Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy.  Hum Reprod. 2001;  16(4) 770-774
• 17 Marret H, Chevillot M, Giraudeau B. Study Group of the French Society of Gynaecology and Obstetrics (Ouest Division) . Factors influencing laparoconversions during the learning curve of laparoscopic myomectomy.  Acta Obstet Gynecol Scand. 2006;  85(3) 324-329
• 18 Dubuisson J B, Fauconnier A, Fourchotte V, Babaki-Fard K, Coste J, Chapron C. Laparoscopic myomectomy: predicting the risk of conversion to an open procedure.  Hum Reprod. 2001;  16(8) 1726-1731
• 19 Tulandi T, Béique F, Kimia M. Pulmonary edema: a complication of local injection of vasopressin at laparoscopy.  Fertil Steril. 1996;  66(3) 478-480
• 20 Martin J D, Shenk L G. Intraoperative myocardial infarction after paracervical vasopressin infiltration.  Anesth Analg. 1994;  79(6) 1201-1202
• 21 Zullo F, Palomba S, Corea D et al.. Bupivacaine plus epinephrine for laparoscopic myomectomy: a randomized placebo-controlled trial.  Obstet Gynecol. 2004;  104(2) 243-249
• 22 Alborzi S, Ghannadan E, Alborzi S, Alborzi M. A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma.  Fertil Steril. 2009;  92(2) 742-747
• 23 Discepola F, Valenti D A, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy.  Obstet Gynecol. 2007;  110(6) 1301-1303
• 24 Agdi M, Tulandi T. The benefits of intrauterine balloon: an intrauterine manipulator and balloon proved useful in myomectomy.  Am J Obstet Gynecol. 2008;  199(5) 581.e1
• 25 Sinha R, Hegde A, Warty N, Mahajan C. Laparoscopic myomectomy: enucleation of the myoma by morcellation while it is attached to the uterus.  J Minim Invasive Gynecol. 2005;  12(3) 284-289
• 26 Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S. Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy.  Fertil Steril. 2008;  89(5) 1247-1253
• 27 Tsuji S, Takahashi K, Yomo H et al.. Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma.  Eur J Obstet Gynecol Reprod Biol. 2005;  123(2) 244-248
• 28 Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kinoshita K. Adhesion-prevention effects of fibrin sealants after laparoscopic myomectomy as determined by second-look laparoscopy: a prospective, randomized, controlled study.  J Reprod Med. 2005;  50(8) 571-577
• 29 Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis G B. Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier.  Hum Reprod. 1995;  10(12) 3133-3135
• 30 Yoo E H, Lee P I, Huh C Y et al.. Predictors of leiomyoma recurrence after laparoscopic myomectomy.  J Minim Invasive Gynecol. 2007;  14(6) 690-697
• 31 Sizzi O, Rossetti A, Malzoni M et al.. Italian multicenter study on complications of laparoscopic myomectomy.  J Minim Invasive Gynecol. 2007;  14(4) 453-462
• 32 Kumakiri J, Takeuchi H, Itoh S et al.. Prospective evaluation for the feasibility and safety of vaginal birth after laparoscopic myomectomy.  J Minim Invasive Gynecol. 2008;  15(4) 420-424
• 33 Hurst B S, Matthews M L, Marshburn P B. Laparoscopic myomectomy for symptomatic uterine myomas.  Fertil Steril. 2005;  83(1) 1-23
• 34 Advincula A P, Song A. Endoscopic management of leiomyomata.  Semin Reprod Med. 2004;  22(2) 149-155
• 35 Advincula A P, Song A, Burke W, Reynolds R K. Preliminary experience with robot-assisted laparoscopic myomectomy.  J Am Assoc Gynecol Laparosc. 2004;  11(4) 511-518
• 36 Advincula A P, Song A. The role of robotic surgery in gynecology.  Curr Opin Obstet Gynecol. 2007;  19(4) 331-336
• 37 Advincula A P, Xu X, Goudeau IV St, Ransom S B. Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs.  J Minim Invasive Gynecol. 2007;  14(6) 698-705
• 38 Nezhat C, Lavie O, Hsu S, Watson J, Barnett O, Lemyre M. Robotic-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy—a retrospective matched control study.  Fertil Steril. 2009;  91(2) 556-559
• 39 Ben-Baruch G, Schiff E, Menashe Y, Menczer J. Immediate and late outcome of vaginal myomectomy for prolapsed pedunculated submucous myoma.  Obstet Gynecol. 1988;  72(6) 858-861
• 40 Wamsteker K, Emanuel M H, de Kruif J H. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension.  Obstet Gynecol. 1993;  82(5) 736-740
• 41 Varasteh N N, Neuwirth R S, Levin B, Keltz M D. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women.  Obstet Gynecol. 1999;  94(2) 168-171
• 42 Hart R, Molnár B G, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis.  Br J Obstet Gynaecol. 1999;  106(7) 700-705
• 43 Varma R, Soneja H, Clark T J, Gupta J K. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up.  Eur J Obstet Gynecol Reprod Biol. 2009;  142(2) 154-159
• 44 Murphy A A, Kettel L M, Morales A J, Roberts V J, Yen S S. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.  J Clin Endocrinol Metab. 1993;  76(2) 513-517
• 45 Murphy A A, Morales A J, Kettel L M, Yen S S. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.  Fertil Steril. 1995;  64(1) 187-190
• 46 Zeng C, Gu M, Huang H. A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone [in Chinese].  Zhonghua Fu Chan Ke Za Zhi. 1998;  33(8) 490-492
• 47 Eisinger S H, Meldrum S, Fiscella K, le Roux H D, Guzick D S. Low-dose mifepristone for uterine leiomyomata.  Obstet Gynecol. 2003;  101(2) 243-250
• 48 Pintiaux A, Chabbert-Buffet N, Foidart J M. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.  Gynecol Endocrinol. 2009;  25(2) 67-73
• 49 Ohara N. Action of progesterone receptor modulators on uterine leiomyomas.  Clin Exp Obstet Gynecol. 2008;  35(3) 165-166
• 50 Spitz I M. Progesterone antagonists and progesterone receptor modulators.  Expert Opin Investig Drugs. 2003;  12(10) 1693-1707
• 51 Olive D L. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.  Obstet Gynecol Surv. 2002;  57(11, suppl 4) S55-S63
• 52 Chwalisz K, Brenner R M, Fuhrmann U U, Hess-Stumpp H, Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium.  Steroids. 2000;  65(10–11) 741-751
• 53 Palomba S, Orio Jr F, Morelli M et al.. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study.  J Clin Endocrinol Metab. 2002;  87(8) 3603-3608
• 54 Parsanezhad M E, Azmoon M, Alborzi S et al.. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.  Fertil Steril. 2010;  93(1) 192-198
• 55 Hilário S G, Bozzini N, Borsari R, Baracat E C. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.  Fertil Steril. 2009;  91(1) 240-243
• 56 Stewart E A, Rabinovici J, Tempany C M et al.. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids.  Fertil Steril. 2006;  85(1) 22-29
• 57 Stewart E A, Gostout B, Rabinovici J, Kim H S, Regan L, Tempany C M. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery.  Obstet Gynecol. 2007;  110(2 Pt 1) 279-287
• 58 Rabinovici J, David M, Fukunishi H et al.. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids.  Fertil Steril. 2010;  93(1) 199-209